126 related articles for article (PubMed ID: 19391038)
1. Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells.
Dong H; Chen L; Chen X; Gu H; Gao G; Gao Y; Dong B
Leuk Lymphoma; 2009 Jun; 50(6):974-84. PubMed ID: 19391038
[TBL] [Abstract][Full Text] [Related]
2. Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.
Wissniowski TT; Meister S; Hahn EG; Kalden JR; Voll R; Ocker M
Int J Oncol; 2012 May; 40(5):1581-9. PubMed ID: 22266985
[TBL] [Abstract][Full Text] [Related]
3. Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells.
Gu H; Chen X; Gao G; Dong H
Mol Cancer Ther; 2008 Aug; 7(8):2298-307. PubMed ID: 18723477
[TBL] [Abstract][Full Text] [Related]
4. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
Nowis D; McConnell EJ; Dierlam L; Palamarchuk A; Lass A; Wójcik C
Int J Cancer; 2007 Jul; 121(2):431-41. PubMed ID: 17373661
[TBL] [Abstract][Full Text] [Related]
5. The proteasome inhibitor bortezomib is a potent inducer of zinc finger AN1-type domain 2a gene expression: role of heat shock factor 1 (HSF1)-heat shock factor 2 (HSF2) heterocomplexes.
Rossi A; Riccio A; Coccia M; Trotta E; La Frazia S; Santoro MG
J Biol Chem; 2014 May; 289(18):12705-15. PubMed ID: 24619424
[TBL] [Abstract][Full Text] [Related]
6. Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells.
Rao R; Nalluri S; Fiskus W; Savoie A; Buckley KM; Ha K; Balusu R; Joshi A; Coothankandaswamy V; Tao J; Sotomayor E; Atadja P; Bhalla KN
Clin Cancer Res; 2010 Oct; 16(19):4742-54. PubMed ID: 20647473
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells.
Chien W; Ding LW; Sun QY; Torres-Fernandez LA; Tan SZ; Xiao J; Lim SL; Garg M; Lee KL; Kitajima S; Takao S; Leong WZ; Sun H; Tokatly I; Poellinger L; Gery S; Koeffler PH
Oncotarget; 2014 Jul; 5(13):4881-94. PubMed ID: 24952679
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.
Nawrocki ST; Carew JS; Dunner K; Boise LH; Chiao PJ; Huang P; Abbruzzese JL; McConkey DJ
Cancer Res; 2005 Dec; 65(24):11510-9. PubMed ID: 16357160
[TBL] [Abstract][Full Text] [Related]
9. [Bortezomib-induced BiP expression and apoptosis in multiple myeloma cells].
Dong HJ; Chen XQ; Gao GX; Gu HT; Pan YZ; Gao Y; Zhu HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):107-10. PubMed ID: 19236758
[TBL] [Abstract][Full Text] [Related]
10. [Effects of xbp-1 gene silencing on bortezomib-induced apoptosis in human multiple myeloma cells].
Yang Y; Dong HJ; Gao GX; Wang YW; Gu HT; Shu MM; Zhu HF; Chen XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1177-80. PubMed ID: 21129256
[TBL] [Abstract][Full Text] [Related]
11. Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways.
Fels DR; Ye J; Segan AT; Kridel SJ; Spiotto M; Olson M; Koong AC; Koumenis C
Cancer Res; 2008 Nov; 68(22):9323-30. PubMed ID: 19010906
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.
Obeng EA; Carlson LM; Gutman DM; Harrington WJ; Lee KP; Boise LH
Blood; 2006 Jun; 107(12):4907-16. PubMed ID: 16507771
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma.
Shirley CM; Chen J; Shamay M; Li H; Zahnow CA; Hayward SD; Ambinder RF
Blood; 2011 Jun; 117(23):6297-303. PubMed ID: 21447826
[TBL] [Abstract][Full Text] [Related]
14. Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition.
Hu J; Dang N; Menu E; De Bruyne E; Xu D; Van Camp B; Van Valckenborgh E; Vanderkerken K
Blood; 2012 Jan; 119(3):826-37. PubMed ID: 22128141
[TBL] [Abstract][Full Text] [Related]
15. Characterization of bortezomib-adapted I-45 mesothelioma cells.
Zhang L; Littlejohn JE; Cui Y; Cao X; Peddaboina C; Smythe WR
Mol Cancer; 2010 May; 9():110. PubMed ID: 20482802
[TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response.
Babcock JT; Nguyen HB; He Y; Hendricks JW; Wek RC; Quilliam LA
J Biol Chem; 2013 May; 288(22):15687-98. PubMed ID: 23612979
[TBL] [Abstract][Full Text] [Related]
17. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
[TBL] [Abstract][Full Text] [Related]
18. Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1.
Ling SC; Lau EK; Al-Shabeeb A; Nikolic A; Catalano A; Iland H; Horvath N; Ho PJ; Harrison S; Fleming S; Joshua DE; Allen JD
Haematologica; 2012 Jan; 97(1):64-72. PubMed ID: 21993678
[TBL] [Abstract][Full Text] [Related]
19. Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma.
Vaeteewoottacharn K; Kariya R; Matsuda K; Taura M; Wongkham C; Wongkham S; Okada S
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1551-62. PubMed ID: 23877657
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis.
Hirai M; Kadowaki N; Kitawaki T; Fujita H; Takaori-Kondo A; Fukui R; Miyake K; Maeda T; Kamihira S; Miyachi Y; Uchiyama T
Blood; 2011 Jan; 117(2):500-9. PubMed ID: 20956804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]